Yingxia Tan

Prof. Yingxia Tan

Department of Stem Cell and Regenerative Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Theranostics
Verified
Journal Article
Open access
PDF file
XQXiaochen Qiu
Xiaochen Qiu
PZPengfei Zhong
Pengfei Zhong
LYLiang Yue
Liang Yue
CLChaofan Li
Chaofan Li
ZYZhimin Yun
Zhimin Yun
BPBao Pengtao
Bao Pengtao
Granulomas are a key pathological feature of tuberculosis (TB), characterized by cell heterogeneity, spatial composition, and cellular interactions, which play crucial roles in granuloma progression and host prognosis. This study aims to analyze the transcriptome profiles of cell populations based on their spatial location and to understand the core transcriptome characteristics of granuloma formation and development.

20 December 2024 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
HCHu Cao
Hu Cao
LYLiang Yue
Liang Yue
JSJingyuan Shao
Jingyuan Shao
FKFanxuan Kong
Fanxuan Kong
SLShenghua Liu
Shenghua Liu
HWHua Wang
Hua Wang
Radiation-induced heart disease (RIHD) is one of the most serious complications of radiation therapy (RT) for thoracic tumors, and new interventions are needed for its prevention and treatment. Small extracellular vesicles (sEVs) from stem cells have attracted much attention due to their ability to repair injury. However, the role of umbilical cord mesenchymal stem cell (UCMSC)-derived sEVs in protecting cardiac organoids from radiation-induced injury and the underlying mechanisms are largely unknown. A radiation-induced cardiac organoid injury model was established by using X-ray radiation, and the optimal radiation dose of 20 Gy was determined by live/dead staining. After radiation, the cardiac organoids were treated with sEVs derived from UCMSCs, and energy metabolism, calcium transient changes and the ultrastructure of the organoids were assessed through Seahorse analysis, optical mapping and transmission electron microscopy, respectively. Confocal microscopy was used to observe the changes in mitochondrial ROS and mitochondrial membrane potential (ΔΨm). Furthermore, real-time quantitative PCR was used to verify the RNA-seq results. After X-ray radiation, the mortality of cardiac organoids significantly increased, energy metabolism decreased, and calcium transients changed. We also observed that the mitochondrial structure of cardiac organoids was disrupted and that ΔΨm was decreased. These effects could be inhibited by sEVs treatment. sEVs may protect against radiation-induced cardiac organoid injury by regulating oxidative phosphorylation and the p53 signaling pathway. sEVs derived from UCMSCs can be used as a potential therapeutic strategy for radiation-induced heart disease.

1 June 2023 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
JYJing Yi
Jing Yi
LYLiang Yue
Liang Yue
YZYuning Zhang
Yuning Zhang
NTNing Tao
Ning Tao
HDHan Duan
Han Duan
HWHua Wang
Hua Wang
Effective strategies are still lacking for treating RIHD, with unclear pathological mechanisms. In cardiomyocytes model of radiation-induced injuries, we found γ-ray irradiation decreased the expression of PTPMT1, increased oxidative stress, and induced mitochondrial dysfunction and necroptosis in iPSC-CMs. ROS inhibition attenuated radiation-induced mitochondrial damage and necroptosis. PTPMT1 protected cardiomyocytes from necroptosis induced by γ-ray irradiation by alleviating mitochondrial injury. Therefore, PTPMT1 might be a potential strategy for treating RIHD.

1 November 2015 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
HGHong-Wei Gao
Hong-Wei Gao
SLSu-Bo Li
Su-Bo Li
WSWendell Q. Sun
Wendell Q. Sun
ZYZhi-Min Yun
Zhi-Min Yun
XZXue Zhang
Xue Zhang
FGFeng Gong
Feng Gong
The α-Gal (Galα1,3-Galβ1-4GlcNAc-R) epitope, the major xenoantigen, is the first barrier in a porcine-to-man tissue and organ xenotransplantation. The elimination or reduction of the α-Gal epitopes is therefore an important step for a successful xenotransplantation. The present study is to evaluate the α-Gal elimination in the porcine skin with α-galactosidase treatment, and to assess two methods (immunohistochemistry and inhibition ELISA) that may be used in quality control for quantifying the extent of the α-Gal elimination. Enzymatic cleavage in a single step process is extremely efficient and affordable at eliminating the α-Gal epitope even in a tissue as dense as the porcine dermis. The cost of enzymatic cleavage is found to be less than US$7 for a 10cm x 10cm piece of porcine skin (0.5 mm thick) or about US$140 for 100g of 3-dimensional soft tissues. After enzymatic cleavage, the α-Gal-positive immunostaining was essentially undetectable in enzyme-treated porcine skin. The inhibition rate constant of the monoclonal anti-Gal antibody M86 binding to α-gal-BSA in ELISA was reduced from 15.0 ± 4.3 (N = 10) to 6.1 ± 2.6 (N = 7) after enzyme treatment, in comparison to 4.4 ± 1.8 (N = 9) background inhibition of decellularized human skin (the ultimate negative control), which demonstrates ~84% elimination of α-Gal epitopes in treated porcine skin. To examine the suitability of two detection methods for the routine quality control application, comparative studies were made with control and enzyme-treated porcine skin, porcine skin from the α-Gal knockout animal, as well as decellularized human skin. The data show that the traditional immunohistochemistry and, to a less extent, the inhibition ELISA with further modifications can be used as quality control tools in the production and selection of biocompatibile bioprosthetic devices. The biological evaluation of enzyme-treated porcine skin is ongoing with a small animal model and a non-human primate model.

1 November 2018 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
PZPingyi Zhang
Pingyi Zhang
SLSubo Li
Subo Li
SZShikun Zhang
Shikun Zhang
XZXue Zhang
Xue Zhang
LWLuming Wan
Luming Wan
YWYiqian Wan
Yiqian Wan

3 June 2024 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
QLQi Liu
Qi Liu
LYLiang Yue
Liang Yue
JDJiu Deng
Jiu Deng
YTYingxia Tan
Yingxia Tan
CWChengjun Wu
Chengjun Wu
The three-dimensional (3D) kidney organoid is a breakthrough model for recapitulating renal morphology and function in vitro, which is grown from stem cells and resembles mammalian kidney organogenesis. Currently, protocols for cultivating this model from induced pluripotent stem cells (iPSCs) and patient-derived adult stem cells (ASCs) have been widely reported. In recent years, scientists have focused on combining cutting-edge bioengineering and bioinformatics technologies to improve the developmental accuracy of kidney organoids and achieve high-throughput experimentation. As a remarkable tool for mechanistic research of the renal system, kidney organoid has both potential and challenges. In this review, we have described the evolution of kidney organoid establishment methods and highlighted the latest progress leading to a more sophisticated kidney transformation research model. Finally, we have summarized the main applications of renal organoids in exploring kidney disease.